Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy

By sjmartinez • November 2, 2023

McDermott MSJ, Browne BC, Conlon NT, O'Brien NA, Slamon DJ, Henry M, Meleady P, Clynes M, Dowling P, Crown J, O'Donovan N. Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy. Mol Cancer. 2023 Oct 30;22(1):175. doi: 10.1186/s12943-023-01890-z. Erratum for: Mol Cancer. 2014 Jun 24;13:157. PMID: 37915024.

Tags: Hematology/Oncology, Publications

Oncofertility patterns after the overturn of Roe v. Wade

Baclig NV, Silverstein J, Shah V, Karlan B, Anand SR, Glaspy JA. Oncofertility patterns after the overturn of Roe v. Wade. J Natl Cancer Inst.[...]

Safety First

Moghanaki D, Gower A. Safety First. Int J Radiat Oncol Biol Phys. 2026 May 1;125(1):18. doi: 10.1016/j.ijrobp.2025.12.009. PMID: 42000358.

Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer

LeVee A, Hennessy MA, Idossa D, Leon-Ferre RA, Nanda R, McArthur H. Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer. Am Soc[...]